Department of Epidemiology, College of Public Health and Health Professions and College of Medicine, University of Florida, Gainesville, Florida.
Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
Cancer Epidemiol Biomarkers Prev. 2020 Feb;29(2):379-385. doi: 10.1158/1055-9965.EPI-19-0787. Epub 2019 Dec 23.
Forkhead box protein A1 (FOXA1) promotes luminal differentiation, and hypermethylation of the gene can be a mechanism of developing estrogen receptor-negative (ER) breast cancer. We examined FOXA1 in breast tumor and adjacent normal tissue in relation to reproductive factors, particularly higher parity and no breastfeeding, that are associated with ER tumors.
We performed IHC for FOXA1 in breast tumors ( = 1,329) and adjacent normal tissues ( = 298) in the Women's Circle of Health Study (949 Blacks and 380 Whites). Protein expression levels were summarized by histology (H) scores. Generalized linear models were used to assess FOXA1 protein expression in relation to reproductive factors by ER status.
ER-positive (ER) versus ER tumors had higher FOXA1 protein expression ( < 0.001). FOXA1 expression was higher in tumor versus paired adjacent normal tissue in women with ER or non-triple-negative cancer (both < 0.001), but not in those with ER or triple-negative cancer. Higher number of births (1, 2, and 3+) was associated with lower FOXA1 protein expression in ER tumors [differences in H score, or β = -8.5; 95% confidence interval (CI), -15.1 to -2.0], particularly among parous women who never breastfed (β = -10.4; 95% CI, -19.7 to -1.0), but not among those who breastfed (β = -7.5; 95% CI, -16.9 to 1.8). The associations for ER tumors were similar, although they were not statistically significant.
In this tumor-based study, higher parity was associated with lower FOXA1 expression in ER tumors, and breastfeeding may ameliorate the influence.
These findings contribute to our understanding of FOXA1 methylation and breast cancer etiology.
叉头框蛋白 A1(FOXA1)促进腔面分化,基因的高甲基化可能是雌激素受体阴性(ER)乳腺癌发生的一种机制。我们研究了 FOXA1 在乳腺癌肿瘤及相邻正常组织中的表达与生殖因素的关系,特别是与 ER 肿瘤相关的较高产次和未哺乳。
我们在 Women's Circle of Health Study 中对 1329 例乳腺癌肿瘤( = 1329)和 298 例相邻正常组织( = 298)进行了 FOXA1 的免疫组化(IHC)检测(949 名黑人,380 名白人)。通过组织学(H)评分总结蛋白表达水平。采用广义线性模型评估 FOXA1 蛋白表达与生殖因素的关系,同时考虑 ER 状态。
ER 阳性(ER)与 ER 肿瘤相比,FOXA1 蛋白表达更高(<0.001)。在患有 ER 或非三阴性癌症的女性中,肿瘤与配对的相邻正常组织相比,FOXA1 表达更高(均<0.001),但在患有 ER 或三阴性癌症的女性中则不然。生育次数较高(1、2 和 3+)与 ER 肿瘤中 FOXA1 蛋白表达降低相关[H 评分差异,或β=-8.5;95%置信区间(CI),-15.1 至-2.0],特别是在从未哺乳的多产妇中(β=-10.4;95%CI,-19.7 至-1.0),但在哺乳的女性中则不然(β=-7.5;95%CI,-16.9 至 1.8)。ER 肿瘤的相关性相似,但无统计学意义。
在这项基于肿瘤的研究中,较高的产次与 ER 肿瘤中 FOXA1 表达降低相关,而哺乳可能会减轻这种影响。
这些发现有助于我们理解 FOXA1 甲基化和乳腺癌病因。